Celaid Therapeutics Inc. announced that it successfully completed the first close of its Series B financing. It raised…
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, announced the successful completion of…
Sign in to your account